United States
Germany
Japan
United Kingdom
China
Dgcr6 (NM_010047) Mouse Tagged ORF Clone Lentiviral Particle
CAT＃: MR223590L4V
- LentiORF®
-
Lenti ORF particles, Dgcr6 (GFP-tagged) - Mouse DiGeorge syndrome critical region gene 6 (Dgcr6), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,360.00
货期*
详询
规格
Product images
经常一起买 (2)
Specifications
| Product Data | |
| Product Name | Dgcr6 (NM_010047) Mouse Tagged ORF Clone Lentiviral Particle |
| Vector | pLenti-C-mGFP-P2A-Puro |
| ACCN | NM_010047 |
| ORF Size | 510 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(MR223590).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_010047.3, NP_034177.1 |
| RefSeq Size | 1262 bp |
| RefSeq ORF | 513 bp |
| Locus ID | 13353 |
| Gene Summary | This gene encodes a protein that is similar to the gonadal protein in Drosophila (fruit fly). The encoded protein is thought to play a role in migration of neural crest cells during development. Deletions in the human gene are associated with DiGeorge syndrome (or velocardiofacial syndrome) which has many clinical features including cardiac abnormalities, cleft palate, atypical facial features, hypocalcemia, hypoparathyroidism and defective development or congenital absence of the thymus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
